Stock 002399 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Equities

002399

CNE100000P02

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-05 pm EDT 		5-day change 1st Jan Change
11.03 CNY +6.47% Intraday chart for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. +19.63% -5.97%
Apr. 29 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Shenzhen Hepalink Receives Thai Approval for Blood Clot Drug Exarane MT

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Provides Earnings Guidance for the Period from January 1, 2022 to June 30, 2022
CI
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2021
CI
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Provides Earnings Guidance for the Second Quarter and First Half Ended June 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002399 Stock
  4. News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
  5. Transcripts
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW